Author Information
Alicia Rodríguez-Gascón is affiliated with the Pharmacokinetic, Nanotechnology & Gene Therapy Group (PharmaNanoGene) at the Faculty of Pharmacy, Centro de investigación Lascaray ikergunea, University of the Basque Country UPV/EHU, located in Vitoria-Gasteiz, Spain. Her research spans across the fields of pharmacokinetics, nanotechnology, and gene therapy, leveraging her expertise to address various medical and scientific challenges.Research Contributions
Alicia Rodríguez-Gascón has made significant contributions to the field of pharmacokinetics and nanomedicine, with a particular focus on the development and optimization of therapeutic strategies for infectious diseases and genetic conditions. Her recent work includes the optimization of dosing regimens for critically ill patients, the development of mRNA-based nanomedicinal products to mitigate corneal inflammation, and the evaluation of antimicrobial therapies through pharmacokinetic/pharmacodynamic (PK/PD) analysis. Her diverse research also extends to gene therapy applications, such as non-viral gene therapy for Fabry Disease.Aliases
Alicia Rodríguez-Gascón is also known by several aliases, including A Rodríguez-gascón, Alicia Rodríguez-gascón, Alicia Rodríguez-gascón, Alicia Rodriguez-gascón, and A. Rodríguez-gascón.Publication and Citation Metrics
| Citation Count |
2597 |
| h-index |
26 |
| Paper Count |
79 |
